Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record.

Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation

Open access
Fondevila, C., Hessheimer, A.J., Flores, E., Ruiz, A., Mestres, N., Calatayud, D., Paredes, D., Rodríguez, C., Fuster, J., Navasa, M., Rimola, A., Taurá, P., García-Valdecasas, J.C. · 2012 · American Journal of Transplantation

Abstract

Maastricht type 2 donation after cardiac death (DCD) donors suffer sudden and unexpected cardiac arrest, typically outside the hospital; they have significant potential to expand the donor pool. Herein, we analyze the results of transplanted livers and all potential donors treated under our type 2 DCD protocol. Cardiac arrest was witnessed; potential donors arrived at the hospital after attempts at resuscitation had failed. Death was declared based on the absence of cardiorespiratory activity during a 5-min no-touch period. Femoral vessels were cannulated to establish normothermic extracorporeal membrane oxygenation, which was maintained until organ recovery. From April 2002 to December 2010, there were 400 potential donors; 34 liver transplants were performed (9%). Among recipients, median age, model for end-stage liver disease and cold and reperfusion warm ischemic times were 55 years (49-60), 19 (14-21) and 380 (325-430) and 30 min (26-35), respectively. Overall, 236 (59%) and 130 (32%) livers were turned down due to absolute and relative contraindications to donate, respectively. One-year recipient and graft survivals were 82% and 70%, respectively (median follow-up 24 months). The applicability of type 2 DCD liver transplant was <10%; however, with better preservation technology and expanded transplant criteria, we may be able to improve this figure significantly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-6143.2011.03834.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 202

Metadata

Authors
Fondevila, C., Hessheimer, A. J., Flores, E., Ruiz, A., Mestres, N., Calatayud, D., Paredes, D., Rodríguez, C., Fuster, J., Navasa, M., Rimola, A., Taurá, P., & García-Valdecasas, J. C.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2012-01
Volume
12
Issue
1
Pages
162-170
ISSN
1600-6135 (ISSN-L)
OpenAlex
W1498277280
Cited by
202
References
0
FWCI
15.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation. https://app.cochat.ai/papers/10.1111/j.1600-6143.2011.03834.x
The paper
Fondevila, C., Hessheimer, A. J., Flores, E., Ruiz, A., Mestres, N., Calatayud, D., Paredes, D., Rodríguez, C., Fuster, J., Navasa, M., Rimola, A., Taurá, P., & García-Valdecasas, J. C. (2012). Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2011.03834.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.